Direxion Daily S&P Biotech Bull 3x Shares Rating $60.70 +3.47 (+6.06%) Closing price 07/2/2025 04:10 PM EasternExtended Trading$61.84 +1.14 (+1.88%) As of 07:02 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOwnershipRatingsShort InterestBuy This Stock Direxion Daily S&P Biotech Bull 3x Shares Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.LABU Aggregate RatingModerate Buy 2.74Holdings in LABU have an aggregate rating of Moderate Buy based on 687 analyst ratings issued in the past year covering 44 companies (47.1% of the portfolio).LABU Aggregate Price Target$60.70High Prediction$60.70Average Prediction$60.70Low Prediction$60.70Holdings in LABU have an aggregate price target of $60.70 and a range of $60.70 to $60.70 covering 44 companies (47.1% of the portfolio).LABU Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy15 Buy rating(s)Moderate Buy22 Moderate Buy rating(s)Hold7 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Direxion Daily S&P Biotech Bull 3x Shares Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 44 LABU Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings2.25%INSMInsmed$98.24+0.6%4.0328 of 5 stars3.00$106.80 8.7%172.07%ALNYAlnylam Pharmaceuticals$329.77+2.4%4.2986 of 5 stars2.79$340.00 3.1%24Positive NewsAnalyst Forecast1.93%NTRANatera$161.57+0.5%2.1263 of 5 stars3.00$184.63 14.3%15Positive News1.91%BPMCBlueprint Medicines$128.20-0.1%1.5574 of 5 stars2.27$128.06 -0.1%221.88%NBIXNeurocrine Biosciences$129.40+1.1%4.9367 of 5 stars2.86$162.00 25.2%22Positive News1.86%EXASExact Sciences$53.86-1.4%4.922 of 5 stars2.95$70.40 30.7%22Positive NewsAnalyst Revision1.64%INCYIncyte$68.17-0.8%4.3769 of 5 stars2.22$74.53 9.3%181.54%UTHRUnited Therapeutics$295.22+1.5%4.9948 of 5 stars2.69$386.15 30.8%13Positive NewsAnalyst Forecast1.54%GILDGilead Sciences$111.51-0.2%4.8426 of 5 stars2.78$110.55 -0.9%27Positive NewsInsider Trade1.50%AMGNAmgen$296.85+2.2%4.2689 of 5 stars2.35$307.82 3.7%23Positive News1.47%BIIBBiogen$133.19+2.4%4.9573 of 5 stars2.38$188.48 41.5%321.44%VRTXVertex Pharmaceuticals$457.03+1.1%4.6674 of 5 stars2.54$511.62 11.9%28Positive News1.42%ABBVAbbVie$190.78+0.4%4.9124 of 5 stars2.81$211.29 10.7%27Trending News1.40%EXELExelixis$44.30+1.6%4.7468 of 5 stars2.52$43.56 -1.7%21Positive NewsAnalyst ForecastGap Up1.28%MDGLMadrigal Pharmaceuticals$300.150.0%3.9913 of 5 stars2.89$420.63 40.1%91.27%BBIOBridgeBio Pharma$42.83+0.1%4.7146 of 5 stars2.93$58.85 37.4%14Analyst ForecastInsider Trade1.20%REGNRegeneron Pharmaceuticals$547.74+2.4%4.9397 of 5 stars2.80$813.57 48.5%25Trending NewsAnalyst Downgrade1.20%MRNAModerna$30.28+5.5%4.3651 of 5 stars2.04$46.61 53.9%23Trending NewsOptions Volume1.08%BMRNBioMarin Pharmaceutical$57.17+1.7%4.9441 of 5 stars2.74$93.45 63.5%23Positive News0.99%IONSIonis Pharmaceuticals$43.59+9.1%4.606 of 5 stars2.78$58.25 33.6%18News CoverageAnalyst UpgradeHigh Trading Volume0.98%TGTXTG Therapeutics$36.29+2.5%3.7706 of 5 stars2.80$40.80 12.4%50.97%RVMDRevolution Medicines$37.19+0.8%4.4993 of 5 stars3.00$67.58 81.7%12Analyst RevisionGap Up0.97%CRSPCRISPR Therapeutics$51.67+6.5%2.9794 of 5 stars2.53$71.75 38.9%170.88%HALOHalozyme Therapeutics$53.84+1.7%4.8145 of 5 stars2.17$61.90 15.0%12Analyst Revision0.85%ROIVRoivant Sciences$10.97+0.3%1.9443 of 5 stars3.00$17.50 59.5%40.78%SWTXSpringWorks Therapeutics$46.991.558 of 5 stars2.13$52.57 11.9%80.72%VKTXViking Therapeutics$27.72+3.9%4.1795 of 5 stars3.00$87.15 214.4%140.72%CYTKCytokinetics$34.36+2.1%4.2945 of 5 stars2.93$70.92 106.4%150.71%SMMTSummit Therapeutics$22.62+6.7%2.4753 of 5 stars2.79$34.67 53.3%14Analyst Forecast0.68%ACADACADIA Pharmaceuticals$21.24-0.6%4.6944 of 5 stars2.71$27.88 31.2%170.66%ALKSAlkermes$29.00+0.0%4.9168 of 5 stars2.83$40.00 37.9%12Positive NewsAnalyst Revision0.65%PCVXVaxcyte$33.27+1.0%1.8124 of 5 stars3.10$136.50 310.3%10News CoveragePositive News0.64%RNAAvidity Biosciences$29.36+3.2%2.1929 of 5 stars3.06$65.59 123.4%170.60%AKROAkero Therapeutics$51.88+0.9%3.6369 of 5 stars3.00$82.50 59.0%60.59%ADMAADMA Biologics$18.14+1.5%4.1061 of 5 stars3.33$27.67 52.5%30.58%NUVLNuvalent$80.50+3.2%3.736 of 5 stars3.17$119.60 48.6%12Analyst UpgradeInsider Trade0.57%SRRKScholar Rock$35.55+5.3%3.6299 of 5 stars3.14$42.67 20.0%70.56%SLNOSoleno Therapeutics$86.21+4.3%4.2194 of 5 stars3.09$107.10 24.2%110.55%ACLXArcellx$66.34+2.6%2.7994 of 5 stars3.07$111.23 67.7%15Positive News0.54%RYTMRhythm Pharmaceuticals$66.92+2.3%3.7995 of 5 stars3.00$77.31 15.5%130.52%TWSTTwist Bioscience$37.68+2.5%4.4187 of 5 stars2.70$50.40 33.8%10News CoveragePositive News0.50%RAREUltragenyx Pharmaceutical$39.46+8.8%3.9662 of 5 stars2.93$87.00 120.5%14High Trading Volume0.48%KRYSKrystal Biotech$141.35+1.7%4.5572 of 5 stars3.00$211.13 49.4%9News CoverageAnalyst Revision0.48%AGIOAgios Pharmaceuticals$35.35+2.9%4.0733 of 5 stars2.71$58.60 65.8%7 This page (NYSEARCA:LABU) was last updated on 7/3/2025 by MarketBeat.com Staff From Our PartnersTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold prices are breaking records. But while everyone else is fixated on headlines… They're missing somet...Investors Alley | SponsoredA grave, grave error.President Donald Trump made headlines last month with a staggering claim. He stated that since taking offic...Porter & Company | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredAI Meltdown Imminent: Dump These Stocks Now!If you have any money in the markets, especially in AI stocks… Please click here to see Elon Musk’s new inv...Paradigm Press | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredMake 22x more from this summer’s Bitcoin boomBitcoin is on fire again. Wall Street’s piling in. ETFs are smashing volume records. And regular investors ...Brownstone Research | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Direxion Daily S&P Biotech Bull 3x Shares Please log in to your account or sign up in order to add this asset to your watchlist. Share Direxion Daily S&P Biotech Bull 3x Shares With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
